Last reviewed · How we verify
NCT04896359
High Doses Vitamin C and Tissular Repair in Surgical Patients
NA trial testing Vitamin C in Tissue Damage in 80 participants. Completed in 3 March 2021.
3 March 2021
Quick facts
| Lead sponsor | Universidad San Francisco de Quito |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 80 |
| Start date | 15 March 2019 |
| Primary completion | 3 March 2021 |
| Estimated completion | 3 March 2021 |
| Sites | 1 location across Ecuador |
Drugs / interventions tested
- Vitamin C — full drug profile →
- Placebo
Conditions studied
- Tissue Damage — all drugs for Tissue Damage →
Sponsor
Universidad San Francisco de Quito — full company profile →
Who can join
18 and older, any sex, with Tissue Damage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, randomize, double-blind, and placebo-controlled study to evaluate in patients with clinical criteria for any of the following open surgical procedure: (1) cesarean section; (2) aesthetic surgery like abdominoplasty; (3) orthopedic surgery; and (4) abdominal open surgery \[excluding laparoscopic procedures\] will be invited to receive either a high dose of vitamin C (12.5 g) three times (48 h pre-surgery, immediately before surgery and 48 h post-surgery) or its placebo, to evaluate the tissue repair process using an international validated instrument named Patient and Observer Scar Assessment Scale.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04896359
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vitamin C
Trials testing the same drug.
- NCT07476443 — Renoprotective Role of Vitamin C and Coenzyme Q10 in Nephrotoxicity · Phase 2, PHASE3 · not yet recruiting
- NCT07414693 — Effect of Vitamin C on Length of Hospital Stay in Children With Severe Pneumonia · Phase 4 · recruiting
- NCT06971315 — Impact of Vitamin C on Pain Detection and Tolerance Threshold · NA · completed
- NCT06794255 — Exploratory Study on the Role of Vitamin C in Promoting Health in Middle-Aged and Elderly Adults · NA · recruiting
- NCT07341308 — Does Vitamin C Increase the Body Heat Generated By The Nervous System? · NA · recruiting
Other Universidad San Francisco de Quito trials
Trials by the same sponsor.
- NCT06219642 — Mindfulness Intervention Using Virtual Reality in Older Adults With Symptoms of Anxiety and Depression in Ecuador · NA · unknown
- NCT03883334 — Isoprinosine in HIV Patients With Viral Load > 50 y < 200 Copies/mL · Phase 4 · unknown
- NCT04786938 — Effect of Probiotics on the Fecal Resistome During Helicobacter Pylori Eradication Therapy · Phase 4 · completed
- NCT03154502 — Sodium Intake in Ecuadorian Population · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04896359 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad San Francisco de Quito
- Last refreshed: 4 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04896359.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing